LGT Group Foundation’s Idexx Laboratories IDXX Stock Holding History

LGT Group Foundation’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.94M	Sell	3,678 -201	-5%	-$113K	0.02%	164
2026 Q1	$2.18M	Buy	3,879 +3,068	+378%	+$1.97M	0.03%	160
2025 Q4	$553K	Sell	811 -420	-34%	-$286K	0.01%	224
2025 Q3	$763K	Buy	1,231 +66	+6%	+$40.1K	0.01%	215
2025 Q2	$625K	Buy	1,165 +56	+5%	+$26.8K	0.01%	221
2025 Q1	$466K	Buy	+1,109	New	+$482K	0.01%	231
2022 Q1	–	Sell	-1,800	Closed	-$1.19M	–	299
2021 Q4	$1.19M	Buy	+1,800	New	+$1.13M	0.03%	200

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

LGT Group Foundation's IDXX Position: Q2 2026 in Review

LGT Group Foundation reduced its Idexx Laboratories (IDXX) stake by 5.2% in Q2 2026, selling an estimated $113K and leaving 3,678 shares worth $1.94M. The position accounts for 0.02% of the portfolio, ranked #164.

LGT Group Foundation first reported a position in IDXX in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.18M in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

LGT Group Foundation held 3,678 shares of Idexx Laboratories worth $1.94M as of Q2 2026.
LGT Group Foundation sold 201 Idexx Laboratories shares in Q2 2026, an estimated $113K.
Idexx Laboratories made up 0.02% of LGT Group Foundation's portfolio in Q2 2026, its #164 holding.
LGT Group Foundation first reported a position in Idexx Laboratories in Q4 2021 and has held it in 7 quarters since.
LGT Group Foundation's Idexx Laboratories position peaked at $2.18M in Q1 2026.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.